ESMO 2018 | Standard of care and progress with PARP inhibitors for ovarian cancer

Name: Standard of care and progress with PARP inhibitors for ovarian cancer
Uploaded: 2018-10-21T00:00:00.000Z
Duration: 6 min 14 s
Description: Susana Banerjee, MBBS, PhD, FRCP, of the Royal Marsden NHS Foundation Trust, London, UK, speaks at the European Society for Medical Oncology (ESMO) 2018 Congress, in Munich, Germany, about the standard of care and progress with PARP inhibitors for ovarian cancer.

Susana Banerjee • 21 Oct 2018

ESMO 2018

Gynecological Cancer Ovarian Cancer Olaparib

Susana Banerjee, MBBS, PhD, FRCP, of the Royal Marsden NHS Foundation Trust, London, UK, speaks at the European Society for Medical Oncology (ESMO) 2018 Congress, in Munich, Germany, about the standard of care and progress with PARP inhibitors for ovarian cancer.